Pfizer To Seek COVID Booster For Healthy 5- To 11-Year-Olds

The video discusses the authorization of COVID-19 booster shots for children aged 5 to 11. Pfizer's data suggests that a smaller booster dose can help develop antibodies in this age group. Pfizer plans to request formal authorization soon. Currently, Pfizer's vaccine is the only option for children under 12. CDC data shows over 22 million children and adolescents aged 5 to 17 are fully vaccinated, with more than 23% having received a booster. However, vaccination rates for ages 5 to 11 remain low.

What age group is Pfizer seeking authorization for COVID boosters?

• 12 to 15 years

• 3 to 5 years

• 5 to 11 years

• 16 to 18 years

What does Pfizer's new data suggest about the booster dose for young children?

• It is ineffective

• It can help develop antibodies

• It causes severe side effects

• It is not needed

Which company's vaccine is currently available for children under 12?

• AstraZeneca

• Pfizer

• Johnson & Johnson

• Moderna

How many children and adolescents aged 5 to 17 have completed their primary COVID-19 vaccination series according to CDC data?

• Over 10 million

• Over 30 million

• Over 15 million

• Over 22 million

What is the booster uptake percentage among children aged 5 to 17?

• 75%

• 10%

• 23%

• 50%